Merck Asks FDA to Authorize First Pill to Treat COVID-19
The antiviral medication would help ease COVID patients’ symptoms and hasten their recovery.

via REUTERS
Get the Beast Digest newsletter delivered straight to your inbox
By clicking “SIGN UP” you agree to our Terms of Use and Privacy Policy.
Merck has asked the Federal Drug Administration to authorize the first pill to treat COVID-19. The antiviral treatment, which can be taken at home, would help ease COVID-19 patients’ symptoms and shorten recovery times, helping hospitals manage outbreaks. Merck asked the FDA to approve the drug, molnupiravir, for patients who have mild-to-moderate COVID cases but could face hospitalization. “The value here is that it’s a pill so you don’t have to deal with the infusion centers and all the factors around that,” said Dr. Nicholas Kartsonis, who works in the company’s infectious-diseases unit. “I think it’s a very powerful tool to add to the toolbox.” In its own trial, the drug decreased hospitalizations and deaths by half when used on patients in the early stages of COVID-19, Merck said.
Unlock a year of full access to The Daily Beast for $35.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation
Sign in or create an account
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation